norm: longeveronNAICS Pharmaceutical Preparations · USno LEI · CIK 0001721484Max severity: Low

Canonical registry

Longeveron Inc.

ent_019fa1e8638a71679938a14aa2f04631

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Longeveron Inc.
Normalized: longeveron— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001721484
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-02-27
The Company, a pharmaceutical and biotech entity, discloses its cybersecurity governance and risk management program in its 10-K filing. The filing states that cybersecurity threats, including previous incidents, have not materially affected the Company's business, results of operations, or financial condition. No specific breach incident is described.